
Foxard 37.5mg Tablet ER
Marketer
Cubit Healthcare
Salt Composition
Venlafaxine (37.5mg)
Overview Foxard 37.5mg Tablet ER
Anxifree 37.5mg Extended-Release Tablets treat depression and anxiety. This medication modifies brain chemistry, alleviating symptoms like agitation, unease, poor concentration, tiredness, perspiration, rapid heartbeat, and racing thoughts. Take Anxifree 37.5mg ER with food, at the same time daily for consistent blood levels. If a dose is missed, take it immediately upon remembering; avoid skipping doses and complete the prescribed course, even with symptom improvement. Abrupt discontinuation may exacerbate symptoms. Potential side effects include queasiness, vomiting, sleeplessness, reduced appetite, nervousness, bowel irregularity, increased sweating, and sexual difficulties. Dizziness and drowsiness are possible; avoid driving or tasks requiring alertness until the medication's effects are known. These side effects typically subside. Consult your doctor if they persist or are troublesome. Before starting Anxifree 37.5mg ER, disclose any kidney, heart, or liver conditions, or history of seizures. Report any unusual mood or behavioral shifts, worsening depression, or suicidal thoughts to your physician.
Uses of Foxard 37.5mg Tablet ER
Mood disorders encompassing depressive and anxiety symptoms
Major Benefits of Foxard 37.5mg Tablet ER:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consume Foxard 37.5mg Extended-Release Tablet with food.
Common Side effects of Foxard 37.5mg Tablet ER:
- Nausea
- Vomiting
- Dizziness
- Insomnia (difficulty in sleeping)
- Decreased appetite
- Anxiety
- Constipation
- Increased sweating
- Sexual dysfunction
How to use Foxard 37.5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 37.5mg extended-release Foxard tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.
How Foxard 37.5mg Tablet ER works:
Extended-release Foxard 37.5mg tablets elevate brain levels of serotonin and norepinephrine, neurotransmitters crucial for emotional equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Foxard 37.5mg Extended-Release Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Foxard 37.5mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the unborn. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Foxard 37.5mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant. Close observation of newborns for drowsiness and appropriate weight increase is recommended.
DrivingUNSAFE
Driving ability may be impaired by Foxard 37.5mg Extended-Release Tablets due to potential side effects. These side effects include dizziness, confusion, and visual disturbances like blurred vision, all of which can negatively impact driving safety.
KidneyCAUTION
Extended-release Foxard 37.5mg tablets require careful administration for individuals with impaired kidney function. Dosage modification of Foxard 37.5mg extended-release tablets may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should use Foxard 37.5mg Extended-Release tablets cautiously. Dosage modification of Foxard 37.5mg Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Foxard 37.5mg Tablet ER :
Should you forget a Foxard 37.5mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Foxard 37.5mg Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Anisole-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Actions | SNRIs (serotonin-norepinephrine reuptake inhibitors) |
